Senior Director, Patient Reported Outcomes

Accountabilities

• Lead global or regional PRO strategy across assigned assets, programs, therapeutic areas, or portfolios, ensuring patient-centered evidence is integrated throughout the product lifecycle.

• Identify and prioritize evidence gaps and translate strategic priorities into integrated evidence plans, clinical development strategies, medical plans, lifecycle initiatives, launch preparation, and value and access strategies.

• Advise senior leaders and governance bodies on evidence priorities, investment trade-offs, methodological approaches, feasibility, timing, risks, and resource allocation.

• Provide scientific oversight for real-world evidence, observational and comparative effectiveness research, burden-of-illness studies, patient preference research, health economic models, indirect treatment comparisons, evidence syntheses, and value communication.

• Guide the selection and implementation of fit-for-purpose PRO and clinical outcome assessment strategies while ensuring research protocols, analysis plans, models, and interpretations meet high standards of scientific rigor.

• Lead complex evidence-generation programs from conception through dissemination and closure, overseeing budgets, vendors, timelines, risks, contracts, resources, quality controls, and compliance requirements.

• Drive public-company and reporting readiness activities related to evidence generation, governance, documentation, reporting timelines, and disclosure requirements.

• Partner with cross-functional and regional stakeholders to resolve competing priorities, facilitate decisions, communicate trade-offs, and translate complex scientific and economic evidence for technical and nontechnical audiences.

• Lead publication and scientific communication strategies and represent the organization at scientific congresses, professional associations, advisory forums, and other external engagements.

• Build relationships with researchers, clinicians, payers, health economists, patient organizations, and other external experts while maintaining appropriate scientific, compliance, and governance standards.

• Lead, coach, and develop direct reports while providing matrix leadership to cross-functional teams, contractors, and external research partners.

• Strengthen organizational capabilities through functional standards, knowledge sharing, reusable resources, continuous improvement, training, and operating-model enhancements.

Requirements

• Advanced degree such as a Master's, PhD, PharmD, MD, or equivalent in health economics, outcomes research, epidemiology, biostatistics, public health, psychometrics, pharmacy, medicine, or another relevant quantitative or clinical discipline.

• At least 10 years of progressively responsible experience in PRO, real-world evidence, outcomes research, epidemiology, market access evidence, medical affairs, clinical research, or a related discipline, with substantial biopharmaceutical or healthcare-sector experience.

• Demonstrated success developing and executing evidence strategies for complex assets, therapeutic areas, or portfolios in global or multi-regional environments.

• Deep expertise in several relevant methodologies, including observational study design, causal inference, comparative effectiveness, economic modeling, indirect treatment comparisons, evidence synthesis, PRO/COA methods, patient preference research, or analysis of claims, EHR, registry, and clinical-trial data.

• Proven ability to influence senior executives, governance bodies, and cross-functional teams without relying solely on formal authority.

• Strong experience managing complex programs, budgets, vendors, risks, competing priorities, people, and matrix teams.

• Excellent scientific communication, writing, presentation, negotiation, and stakeholder-management skills, with the ability to translate complex evidence into clear recommendations.

• Working knowledge of research, privacy, safety, publication, compliance, and data-governance requirements.

• Experience in oncology and hematology, health technology assessment, reimbursement, regulatory strategy, or value communication across major global markets is strongly preferred.

• A strong publication record and external scientific presence in PRO, epidemiology, health economics, or related disciplines is preferred.

• Experience establishing functional standards, governance frameworks, centers of excellence, or enterprise-wide evidence-generation capabilities is advantageous.

• Familiarity with statistical and analytical software, real-world data sources, economic-modeling applications, literature-review platforms, and regulated content systems is preferred.

• Strong leadership qualities, analytical thinking, financial discipline, inclusiveness, adaptability, initiative, continuous-learning mindset, and results orientation.

• Ability to work effectively across time zones and travel approximately 25–30% domestically and internationally as business needs require.

Benefits

• Base salary range of $222,000–$292,000 annually, with actual compensation determined by factors including skills, experience, education, certifications, and location.

• Eligibility for an annual bonus plan.

• Opportunity to receive discretionary equity awards and participate voluntarily in an employee stock purchase plan.

• Comprehensive medical, dental, and vision coverage.

• 401(k) plan.

• Flexible Spending Account (FSA) and/or Health Savings Account (HSA).

• Life insurance.

• Paid time off.

• Wellness benefits and programs.

• Fully remote work arrangement in the United States.

• Senior leadership opportunity with direct people-management and matrix leadership responsibilities.

• Opportunity to influence global evidence-generation strategies and contribute to patient-centered innovation across major markets.